TY - JOUR
T1 - Determinants of influenza vaccination among solid organ transplant recipients attending Sicilian reference center
AU - Vitale, Francesco
AU - Restivo, Vincenzo
AU - Vizzini, Giovanni
AU - Mularoni, Alessandra
AU - Di Benedetto, Cinzia
AU - Gioè, Santi Mauro
AU - Di Benedetto, Cinzia
AU - Gioe', Santi Mauro
PY - 2017
Y1 - 2017
N2 - Among solid organ transplant recipients, influenza infection is commonly associated with higher morbidity and mortality than immunocompetent hosts. Therefore, in these subjects influenza vaccination is of paramount importance. The main objective of the study was to assess compliance to vaccination and analyze factors associated with influenza vaccination of solid organ transplant recipients admitted to the Sicilian solid organ transplant Reference Center IRCCS-ISMETT in Palermo during 2014–2015 influenza season. Thirty one (37.8%) out of 82 solid organ transplant recipients were vaccinated against influenza. The main reason for vaccination refusal was fear of adverse reaction (n = 16, 31.4%), impaired health status (n = 14, 27.4%) and low vaccine efficacy (n = 10, 19.6%). Vaccinated solid organ transplant recipients compare with unvaccinated had smaller hospital admissions for infectious respiratory diseases (9.7% Vs 23.5%) during surveillance period. On multivariate analysis the factors positively associated with influenza vaccination were the advice of Reference Center physicians (OR 53.4, p < 0.001) and to perform vaccine against pneumococcus (OR 7.0, p = 0.016). This study showed that Reference Center physicians play a key role on vaccine communication and recommendation for patients at risk and it underlines the effectiveness of influenza vaccination in solid organ transplant recipients. However, it remains that, although physician advice resulted a strong determinant for vaccination, influenza vaccination coverage in this subset of population remains still unsatisfactory.
AB - Among solid organ transplant recipients, influenza infection is commonly associated with higher morbidity and mortality than immunocompetent hosts. Therefore, in these subjects influenza vaccination is of paramount importance. The main objective of the study was to assess compliance to vaccination and analyze factors associated with influenza vaccination of solid organ transplant recipients admitted to the Sicilian solid organ transplant Reference Center IRCCS-ISMETT in Palermo during 2014–2015 influenza season. Thirty one (37.8%) out of 82 solid organ transplant recipients were vaccinated against influenza. The main reason for vaccination refusal was fear of adverse reaction (n = 16, 31.4%), impaired health status (n = 14, 27.4%) and low vaccine efficacy (n = 10, 19.6%). Vaccinated solid organ transplant recipients compare with unvaccinated had smaller hospital admissions for infectious respiratory diseases (9.7% Vs 23.5%) during surveillance period. On multivariate analysis the factors positively associated with influenza vaccination were the advice of Reference Center physicians (OR 53.4, p < 0.001) and to perform vaccine against pneumococcus (OR 7.0, p = 0.016). This study showed that Reference Center physicians play a key role on vaccine communication and recommendation for patients at risk and it underlines the effectiveness of influenza vaccination in solid organ transplant recipients. However, it remains that, although physician advice resulted a strong determinant for vaccination, influenza vaccination coverage in this subset of population remains still unsatisfactory.
KW - Immunology
KW - Immunology and Allergy
KW - Pharmacology
KW - counselling
KW - determinants
KW - healthcare workers
KW - immunization factors
KW - immunocompromised
KW - influenza
KW - pneumococcus
KW - solid organ transplant
KW - vaccination uptake
KW - vaccine
KW - Immunology
KW - Immunology and Allergy
KW - Pharmacology
KW - counselling
KW - determinants
KW - healthcare workers
KW - immunization factors
KW - immunocompromised
KW - influenza
KW - pneumococcus
KW - solid organ transplant
KW - vaccination uptake
KW - vaccine
UR - http://hdl.handle.net/10447/226005
UR - http://www.tandfonline.com/loi/khvi20
M3 - Article
SN - 2164-5515
VL - 13
SP - 346
EP - 350
JO - HUMAN VACCINES & IMMUNOTHERAPEUTICS
JF - HUMAN VACCINES & IMMUNOTHERAPEUTICS
ER -